Marina Mata

Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome

Catherine S. Storm, Demis A. Kia, Mona Mohammad Almramhi et al. · Nature Communications · 2021 · 204 citations · Full text

Identification of sixteen novel candidate genes for late onset Parkinson’s disease

Alessandro Gialluisi, Mafalda Giovanna Reccia, Nicola Modugno et al. · Molecular Neurodegeneration · 2021 · 83 citations · Full text

The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population‐Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight

Sara Bandrés‐Ciga, Sarah Ahmed, Marya S. Sabir et al. · Movement Disorders · 2019 · 70 citations · Full text

New form of familial Parkinson‐dementia syndrome

Marina Mata, Katerina Dorovini‐Zis, Mary E. Wilson et al. · Neurology · 1983 · 41 citations

Motor Dysfunction, Parkinsonism Features, Neurological Disorder +20

Impact of SAfinamide on Depressive Symptoms in Parkinson’s Disease Patients (SADness-PD Study): A Multicenter Retrospective Study

Esteban Peña, Carmen Borrué, Marina Mata et al. · Brain Sciences · 2021 · 33 citations · Full text